Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...

The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for chronic spontaneous urticaria on April 18, 2025.

US FDA accepts for review the resubmission of sBLA for Dupixent to treat chronic spontaneous urticaria: Paris Monday, November 18, 2024, 11:00 Hrs [IST] The US Food and Drug Admin ...

Incyte (Nasdaq:INCY) today announced that it will pause enrollment in the ongoing Phase 2 study of MRGPRX2 (INCB000262) in chronic spontaneous urticaria (CSU). The decision was made following the ...

BluPeak Credit Union (BluPeak) is proud to announce an innovative Buy Now, Pay Later (BNPL) solution to its digital banking suite. This strategic move, the first credit union BNPL product for ...

While studying at Cambridge, Thorne was diagnosed with chronic pain condition cholinergic urticaria, and he has often written about pain and disability – but is Joy an even more personal project? "Not ...

Cloudflare, Inc. , the leading connectivity cloud company, has been named a Leader in the IDC MarketScape Worldwide Edge Delivery Services 2024 Vendor Assessment (doc #US51812424, Nov 2024). A total ...

There are dermatologists who don’t have much training in vulvar dermatology, and a lot of gyns don’t get as much training” as ...

Throughout this period, Xolair was available to patients with asthma, and in 2014, it was also approved for idiopathic, or unexplained, chronic hives. Both of these conditions tend to involve high ...

Ozempic (semaglutide) is a well-known prescription drug that’s used to treat blood sugar of people with type 2 diabetes, has ...

Family Carers Ireland, the national charity supporting Ireland’s family carers, has announced that this year’s Netwatch ...

Peanuts, a popular snack, offer a wealth of health benefits when consumed daily in moderation. Packed with protein, healthy ...